Dingal, Christine Joy L.
HRN: 21-33-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
CO-AMOXICLAV 625MG (TAB)
05/13/2022
05/13/2022
PO
625
BID
ACUTE CYSTITIS
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes